CONGENITAL PYELOCALIECTASIS

This adverse event was reported 120 times

These drugs are most commonly taken by patients reporting CONGENITAL PYELOCALIECTASIS:

# Drug Count
0 RILPIVIRINE HYDROCHLORIDE 20
1 LAMOTRIGINE 14
2 CLOBAZAM 10
3 LEVETIRACETAM 9
4 ATAZANAVIR 8
5 LAMIVUDINE AND ZIDOVUDINE 8
6 RITONAVIR 8
7 ALPRAZOLAM 7
8 FOLIC ACID 7
9 LAMOTIRIGINE 7
See all common drugs associated with CONGENITAL PYELOCALIECTASIS

CONGENITAL PYELOCALIECTASIS is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 LAMIVUDINE AND ZIDOVUDINE 8 0.0010
1 CLOBAZAM 10 0.0006
2 ATAZANAVIR 8 0.0006
3 EMTRICITABINE, RILPIVIRINE HYDROCHLORIDE, AND TENOFOVIR ALAFENAMIDE 2 0.0006
4 ESTAZOLAM 1 0.0005
5 MARAVIROC 1 0.0004
6 CABOTEGRAVIR AND RILPIVIRINE 2 0.0003
7 DARUNAVIR 4 0.0003
8 ETRAVIRINE 1 0.0002
9 BELIMUMAB 6 0.0002
See all drugs enriched for association with CONGENITAL PYELOCALIECTASIS